Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

MIXED(8)

DRUG(8)

Ruxolitinib Phosphate Cream

1 trial

phase_2

incyte-corporation

7 unique interventions2 categories

Analytics

Trial Phases

Phase 28

Phase 34

Trial Status

Completed9

Terminated2

Other1

Role Distribution

Other Roles12

Activity Timeline

Clinical Trials (12)

NCT05073458Phase 3Terminated

Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolytic Anemia

Warm Autoimmune Hemolytic Anemia (wAIHA)

StudydirectorStart date: 2022-03-15

NCT05061693Phase 2Completed

A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis

Prurigo Nodularis

StudydirectorStart date: 2021-11-04

NCT04530344Phase 3Completed

Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo

Vitiligo

StudychairStart date: 2020-09-24

NCT04057573Phase 3Completed

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

Non-segmental Vitiligo

StudydirectorStart date: 2019-10-03

NCT04052425Phase 3Completed

Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)

Non-segmental Vitiligo

StudydirectorStart date: 2019-09-20

NCT03627065Phase 2Completed

A Study of INCB050465 in Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

StudydirectorStart date: 2019-02-28

NCT03538041Phase 2Completed

A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia

Autoimmune Hemolytic Anemia

StudydirectorStart date: 2018-11-21

NCT03607487Phase 2Completed

A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Hidradenitis Suppurativa

StudydirectorStart date: 2018-10-15

NCT03569371Phase 2Completed

A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Hidradenitis Suppurativa

StudydirectorStart date: 2018-07-17

NCT03099304Phase 2Completed

A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo

Vitiligo

StudydirectorStart date: 2017-06-07

Showing 10 of 12 trials

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Hidradenitis Suppurativa2 Non-Segmental Vitiligo2 Vitiligo2 Alopecia Areata1 Anemia, Hemolytic, Autoimmune1 Pemphigus Vulgaris1 Primary Sjögren's Syndrome1 Prurigo Nodularis1

Affiliations

Incyte Corporation

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Andrew McGovern, MD

Momentum Data

5 trials

Shared therapeutic areas:

Alopecia AreataVitiligo

Similarity Score7%

Mark Lebwohl, MD

Icahn School of Medicine at Mount Sinai

14 trials

Shared therapeutic areas:

Alopecia AreataVitiligo

Similarity Score7%

Maria K Hordinsky, MD

University of Minnesota

5 trials

Shared therapeutic areas:

Alopecia Areata

Similarity Score3%

Jean-François VIALLARD, Prof

University Hospital, Bordeaux

4 trials

Shared therapeutic areas:

Anemia, Hemolytic, Autoimmune

Similarity Score3%

Xinghua Gao

First Hospital of China Medical University

5 trials

Shared therapeutic areas:

Prurigo Nodularis

Similarity Score3%

Sabine Hazan, MD

ProgenaBiome

41 trials

Shared therapeutic areas:

Hidradenitis Suppurativa

Similarity Score3%

Deran Oskay, Prof

Gazi University

6 trials

Shared therapeutic areas:

Primary Sjögren's Syndrome

Similarity Score3%

David Berk, MD

Arcutis Biotherapeutics, Inc.

17 trials

Shared therapeutic areas:

Vitiligo

Similarity Score3%

Adelaide Hebert, MD

The University of Texas Health Science Center, Houston

2 trials

Shared therapeutic areas:

Alopecia Areata

Similarity Score3%

Robert Bissonnette, MD

Innovaderm Research Inc.

15 trials

Shared therapeutic areas:

Hidradenitis Suppurativa

Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (12)

Showing 12 of 12 trials

NCT05073458Phase 3StudyDirector

Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolytic Anemia

Warm Autoimmune Hemolytic Anemia (wAIHA)

Terminated

NCT05061693Phase 2StudyDirector

A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis

Prurigo Nodularis

Completed

NCT04530344Phase 3StudyChair

Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo

Vitiligo

Completed

NCT04057573Phase 3StudyDirector

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

Non-segmental Vitiligo

Completed

NCT04052425Phase 3StudyDirector

Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)

Non-segmental Vitiligo

Completed

NCT03627065Phase 2StudyDirector

A Study of INCB050465 in Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

Completed

NCT03538041Phase 2StudyDirector

A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia

Autoimmune Hemolytic Anemia

Completed

NCT03607487Phase 2StudyDirector

A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Hidradenitis Suppurativa

Completed

NCT03569371Phase 2StudyDirector

A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Hidradenitis Suppurativa

Completed

NCT03099304Phase 2StudyDirector

A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo

Vitiligo

Completed

NCT02553330Phase 2StudyDirector

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

Alopecia Areata

Terminated

NCT03780166Phase 2StudyDirector

A Study of the Safety and Tolerability of INCB050465 in Pemphigus Vulgaris

Pemphigus Vulgaris

Withdrawn

All 12 trials loaded